Related Experiment Video
Updated: Aug 17, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 14, 2014
I kappa B alpha can localize in the nucleus but shows no direct transactivation potential
1Department of Genetics, University of Pennsylvania, School of Medicine, Philadelphia 19104-6145.
Insights
Inhibitor of kappa B alpha (I kappa B alpha) can act as a transcriptional activator when in the nucleus, interacting with RelA(p65). This protein, typically cytoplasmic, translocates to the nucleus upon cell stimulation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Transcription Regulation
Background:
- Inhibitor of kappa B alpha (I kappa B alpha) is known as a cytoplasmic inhibitor of Nuclear Factor kappa B (NF-kappa B) and c-Rel, preventing NF-kappa B nuclear translocation.
- Some proteins with ankyrin-type repeats function as transcription factors, suggesting potential nuclear roles for I kappa B family members.
- Previous studies indicate that certain forms of I kappa B can be found in the nucleus, challenging their exclusively cytoplasmic role.
Purpose of the Study:
- To investigate whether a nuclear form of I kappa B alpha possesses transcriptional activator properties.
- To identify the specific domain of I kappa B alpha responsible for transactivation.
- To understand the cellular localization dynamics of I kappa B alpha and its association with NF-kappa B components.
Main Methods:
- Generation and testing of Gal4-I kappa B alpha fusion proteins for transactivation activity in 3T3 fibroblasts.
- Domain mapping to pinpoint the region of I kappa B alpha mediating transactivation.
- Immunofluorescence and cell fractionation studies to determine I kappa B alpha localization under different cellular conditions.
- Double antibody immunoprecipitation to assess I kappa B alpha association with RelA(p65).
Main Results:
- Gal4-I kappa B alpha fusion proteins demonstrated strong transactivation of a Gal4 site-containing promoter.
- The ankyrin repeat domain of I kappa B alpha, not the acidic domain, was identified as crucial for transactivation.
- Overexpressed I kappa B alpha localized to the nucleus in serum-stimulated cells but remained largely cytoplasmic in serum-deprived cells.
- I kappa B alpha was found to associate with RelA(p65) in proliferating cells and in nuclear Gal4-I kappa B alpha fusions.
- The transactivation ability of Gal4-I kappa B alpha is attributed to the activation domain of associated RelA(p65), not direct transactivation by I kappa B alpha itself.
Conclusions:
- I kappa B alpha can function as a transcriptional activator, mediated by its ankyrin repeat domain and interaction with RelA(p65).
- Cellular stimulation induces nuclear translocation of I kappa B alpha, enabling its role in transcription.
- Unlike Bcl-3, I kappa B alpha does not directly transactivate promoters through kappa B sites when bound to RelA(p65).
Abstract:
Although I kappa B is a cytoplasmic inhibitor of NF-kappa B and c-Rel that prevents nuclear translocation of NF-kappa B, some forms of I kappa B have been found in the nucleus. Given that some other proteins with ankyrin-type repeats are transcription factors, we wondered if a nuclear form of I kappa B alpha could itself be a transcriptional activator. We found that Gal4-I kappa B alpha fusion proteins strongly transactivate a Gal4 site-containing promoter in 3T3 fibroblasts. The I kappa B alpha domain responsible for this transactivation is not the acidic domain of I kappa B alpha, but the ankyrin repeat domain which is responsible for protein-protein interactions. To enhance our ability to detect cellular I kappa B alpha by immunofluorescence, we overexpressed the protein in transfected cells, and found that overexpressed I kappa B alpha is largely cytoplasmic in serum-deprived cells, but nuclear in serum-stimulated cells. However, in cell fractionation studies under all treatment conditions, I kappa B alpha appears mainly in cytoplasmic fractions, suggesting that it can rapidly move out of the nucleus through nuclear pores during extract preparation. Using double antibody immunoprecipitations, we found that I kappa B alpha in proliferating cells is strongly associated with RelA(p65). When I kappa B alpha is fused to the Gal4 DNA-binding domain, nuclear Gal4-I kappa B alpha is associated with RelA(p65). Thus, the activation domain of the associated RelA(p65) molecule could account for the ability of Gal4-I kappa B alpha to transactivate the Gal4 promoter. Unlike Bcl-3, an I kappa B which has been recently shown to directly transactivate through kappa B sites when associated with NFKB2 (p52), I kappa B alpha shows no ability to directly transactivate target promoters via its association with RelA(p65).
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
General Transcription Factors

